Sleep Apnea cardioVascular Endpoints (SAVE) trial

D. McEvoy, N. Antic, E. Heeley, Y. Huang, S. Huang, J. Wang, B. Chen, Q. He, N. Zhong, C. Anderson (Adelaide, Sydney, Australia; Shanghai, , Beijing, Tianjin, China)

Source: Annual Congress 2010 - News from RCT (randomised controlled trials) and epidemiology in sleep apnoea
Session: News from RCT (randomised controlled trials) and epidemiology in sleep apnoea
Session type: Oral Presentation
Number: 1664
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. McEvoy, N. Antic, E. Heeley, Y. Huang, S. Huang, J. Wang, B. Chen, Q. He, N. Zhong, C. Anderson (Adelaide, Sydney, Australia; Shanghai, , Beijing, Tianjin, China). Sleep Apnea cardioVascular Endpoints (SAVE) trial. Eur Respir J 2010; 36: Suppl. 54, 1664

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Obstructive Sleep Apnea (OSAS) in a clinical cohort of children. Atlantis Study
Source: International Congress 2017 – What is new in respiratory and sleep physiology?
Year: 2017

LATE-BREAKING ABSTRACT: ORCADES: Efficacy and Tolerability of a Custom-Made CAD/CAM Mandibular Repositioning Device (MRD) For Treating Obstructive Sleep Apnoea (OSA)
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014



LATE-BREAKING ABSTRACT: A Randomized Controlled Study of Upper Airway Stimulation Therapy Withdrawal Effect in Treatment of Obstructive Sleep Apnea
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013

The sleepy phenotype in mild Obstructive  Sleep Apnoea (OSA) patients: from clinical characteristics to cardiometabolic risk. Data from the European Sleep Apnea Database (ESADA).
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021


The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Late-breaking abstract: Nocturnal intermittent hypoxia strongly predicts systemic hypertension in the European Sleep Apnoea Cohort Study
Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea
Year: 2011


The munich sleep endoscopy protocoll (MSEP)
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014

Positional therapy as a treatment for central sleep apnoea: A prospective multicentre trial
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016

Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



Telemedicine-based strategy for sleep apnea management: A multicenter randomized controlled trial
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014

Nasal steroids in snorers can decrease snoring frequency – A randomized placebo-controlled crossover trial
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014


Late Breaking Abstract - Effectiveness of multimodal remote patient monitoring at CPAP initiation in Obstructive Sleep Apnea (OSA) with high cardiovascular risk: A randomized trial
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017

Can the OSLER MWT be improved?
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


The effect of CPAP on quality of life in patients with ‘very’ mild Obstructive Sleep Apnoea (OSA): Results from a subset of the MERGE Randomised Trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017



Investigation of Sleep Apnea During Elderly
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019

Self Reported Sleepiness At The Wheel Versus Apnea Hypopnea Index To Predict Sleep Related Accidental Risk Of Patients Suspected Obstructive Sleep Apnea Syndrome
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018


Can the Sleep Clinical Record diagnose moderate-to-severe Obstructive Sleep Apnea Syndrome in children?
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021


Prospective echocardiographic study of right and left cardiac function during sleep in obstructive sleep apnea syndrome: Assessment at 1 month and 6 months of treatment with CPAP
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014

Polysomnographic and Clinical Characteristics of Positional Obstructive Sleep Apnea Patients
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021